menu
    • menu

    Company profile for Veracyte

    NEW Drugs in Dev: 1
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Veracyte is a pioneering genomic diagnostics company. Our tests are dramatically improving clinical outcomes for patients by resolving inconclusive results from traditional diagnostic methods. We ask the right questions to resolve ambiguity and bring assurance to light, rendering tens of thousands of costly and unnecessary surgeries truly unnecessary. We are giving patients a clearer path forward.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VeracyteUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6000 Shoreline Court \nSuite 300 \nSouth San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.veracyte.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Veracyte Launches Prosigna Breast Test in the U.S.
    Veracyte Launches Prosigna Breast Test in the U.S.

    01 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260601512881/en/Veracyte-Announces-Commercial-Launch-of-the-Prosigna-Breast-Test-in-the-U.S.

    BUSINESSWIRE
    01 Jun 2026
    Share Share
    ENZAMET Trial Validates Decipher in Metastatic Prostate Cance
    ENZAMET Trial Validates Decipher in Metastatic Prostate Cance

    30 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260530183615/en/ENZAMET-Trial-Shows-Veracytes-Decipher-Prostate-Test-Identifies-Which-Patients-Benefit-from-Adding-Chemotherapy-in-Metastatic-Prostate-Cancer

    BUSINESSWIRE
    30 May 2026
    Share Share
    OPTIMA Trial Shows Prosigna Identifies Chemo-Sparing Patients
    OPTIMA Trial Shows Prosigna Identifies Chemo-Sparing Patients

    29 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260528130751/en/Landmark-OPTIMA-Trial-Delivers-Practice-Changing-Evidence-that-Veracytes-Prosigna-Test-Identifies-Patients-with-High-Risk-Breast-Cancer-Who-Can-Safely-Avoid-Chemotherapy

    BUSINESSWIRE
    29 May 2026
    Share Share
    Veracyte to Host Investor Call on June 1 to Discuss ASCO Findings
    Veracyte to Host Investor Call on June 1 to Discuss ASCO Findings

    22 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260522044871/en/Veracyte-to-Host-Investor-Call-on-June-1-2026-to-Discuss-ASCO-Findings

    BUSINESSWIRE
    22 May 2026
    Share Share
    Veracyte Gains Coverage for Bladder Cancer Monitoring Test
    Veracyte Gains Coverage for Bladder Cancer Monitoring Test

    15 May 2026

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/veracyte-gains-medicare-coverage-for-muscle-invasive-bladder-cancer-recurrence-monitoring-test/

    CONTRACTPHARMA
    15 May 2026
    Share Share
    Veracyte Announces Q1 2026 Financial Results
    Veracyte Announces Q1 2026 Financial Results

    05 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260505667065/en/Veracyte-Announces-First-Quarter-2026-Financial-Results

    BUSINESSWIRE
    05 May 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search